Table 2.
Locus | rs number | SNP | Frequency | HIV RNA in plasma at set point, median and (IQR) |
Mann–Whitney U-test P-value |
HLA-B*5701 association of given SNP allele |
HLA-C*0602 association of given SNP allele |
|
---|---|---|---|---|---|---|---|---|
(a) | ||||||||
HCP5 | rs2395029 | TTa | 0.929 | 18 010 (4456–41 680) | TT vs GT or GG | 5 of 916 | 117 of 916 | |
GTa | 0.069 | 3648 (627–11 701) | P=7 × 10−7 | 64 of 69 | 61 of 69 | |||
GGb | 0.002 | 2 of 2 | 2 of 2 | |||||
TTa | 0.383 | 21 980 (5104–49 850) | TT vs CT P<0.07 | 2 of 377 | 1 of 377 | |||
5′ HLA-C | rs9264942 | CTa | 0.482 | 15 480 (3558–37 050) | CT vs CC P<0.03 | 41 of 475 | 111 of 475 | |
CCb | 0.135 | 7918 (1060–20 780) | CC vs TT P<0.002 | 28 of 133 | 68 of 133 | |||
(b) | ||||||||
Locus | rs number | SNP |
HLA-B*5701 association (+indicates heterozygosity)c |
Frequency of genotype, frequency with set point |
HIV RNA in plasma at set point, median and (IQR) |
Mann–Whitney U-test P-value against heterozygous |
||
|
||||||||
5′ HLA-C | rs9264942 | TT | + | 2, 1 | 20320 | 0.298 | ||
CTa | + | 41, 14 | 4920 (732, 12 430) | |||||
CCb | + | 26, 12 | 773 (300–7443) | 0.167 | ||||
TT | − | 375, 137 | 21 980 (4975, 49820) | 0.328 | ||||
CTa | − | 434, 182 | 17 000 (4359, 39700) | |||||
CCb | − | 105, 34 | 11 430 (4464–32 600) | 0.341 | ||||
(c) | ||||||||
Locus | rs number | SNP |
HCP5 SNP associationd |
Frequency of genotype, frequency with set point |
HIV RNA in plasma at set point, median and (IQR) |
Mann–Whitney U-test P-value against heterozygous |
||
|
||||||||
5′ HLA-C | rs9264942 | TT | GT | 2, 2 | 17 110 (15 510–18 710) | 0.158 | ||
CTa | GT | 41, 22 | 4920 (720–11 720) | |||||
CCb | GT | 26, 11 | 708 (300–5295) | 0.057 | ||||
TT | TT | 379, 137 | 23 200 (4975, 49890) | 0.258 | ||||
CTa | TT | 439, 184 | 17 000 (4346–39 570) | |||||
CCb | TT | 106, 36 | 11 430 (4935–29 490) | 0.324 |
Abbreviations: HIV, human immunodeficiency virus; HLA, human leukocyte antigen; IQR, interquartile range; SNP, single nucleotide polymorphism.
Major SNP alleles.
Minor SNP alleles.
Two individuals homozygous for HLA-B*5701 were omitted to avoid confounding.
Two patients with HCP5 with GG homozygosity were omitted to avoid confounding.
Note: analysis was carried out without correction for multiple comparisons suggested by previous studies.